Pola Orbis (OTCMKTS:PORBF) and Waldencast (NASDAQ:WALD) Financial Comparison

Waldencast (NASDAQ:WALD) and Pola Orbis (OTCMKTS:PORBF) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent ratings for Waldencast and Pola Orbis, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	0	1	5	0	2.83
Pola Orbis	0	0	0	0	0.00

Waldencast currently has a consensus target price of $4.9714, indicating a potential upside of 187.37%. Given Waldencast’s stronger consensus rating and higher probable upside, analysts clearly believe Waldencast is more favorable than Pola Orbis.

Valuation and Earnings

This table compares Waldencast and Pola Orbis”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$273.87 million	0.77	-$42.44 million	N/A	N/A
Pola Orbis	$1.13 billion	1.95	$58.71 million	$0.19	52.37

Pola Orbis has higher revenue and earnings than Waldencast.

Risk and Volatility

Waldencast has a beta of -0.46, meaning that its stock price is 146% less volatile than the S&P 500. Comparatively, Pola Orbis has a beta of 0.27, meaning that its stock price is 73% less volatile than the S&P 500.

Profitability

This table compares Waldencast and Pola Orbis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
Pola Orbis	3.81%	5.16%	4.30%

Insider and Institutional Ownership

42.0% of Waldencast shares are held by institutional investors. 5.9% of Waldencast shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Pola Orbis beats Waldencast on 7 of the 12 factors compared between the two stocks.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. The company is headquartered in White Plains, New York.

About Pola Orbis

Pola Orbis Holdings Inc., through its subsidiaries, develops, manufactures, and sells cosmetics and related products in Japan and internationally. It operates through Beauty Care and Real Estate segments. The Beauty Care segment offers cosmetics; skincare products; health foods; and fashion products, such as women's underwear, women's apparel, and jewelry under the POLA, ORBIS, Jurlique, H2O PLUS, THREE, DECENCIA, Amplitude, ITRIM, FIVEISM × THREE, and FUJIMI brand names. The Real Estate segment is involved in the leasing of office buildings and residential properties. The company also involves in the management and operation of buildings. It sells its products through department, directly operated retail, duty-free stores, Internet, and cosmetics stores, as well as through door-to-door sales, and mail-order sales. Pola Orbis Holdings Inc. was founded in 1929 and is headquartered in Tokyo, Japan.